Monash IVF Group logo

Monash IVF Group(ASX) MVF

Market CapA$290.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-31%
5 Year-6%
1 Year+7%
1 Month-6%
A$0.75
+0.67%
+0.00Today
Monash IVF Group last closing stock price
MetricPriceDate
Last closeAUD 0.752026-10-13
Monash IVF Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.66%AUD 0.762026-10-06
1 month-5.66%AUD 0.802026-09-11
3 month+8.21%AUD 0.692026-07-15
Year to date+5.67%AUD 0.712025-12-31
1 year+7.13%AUD 0.702025-10-13
3 year-35.04%AUD 1.152023-10-13
5 year-5.75%AUD 0.802021-10-14
Since inception-30.74%AUD 1.082014-06-26

Monash IVF Group Financials at a Glance

Market Cap

A$290.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$541.38M

Net Income (TTM)

A$32.43M

EPS (TTM)

A$0.02

P/E Ratio

39.01

Dividend

A$0.03

Beta (Volatility)

0.04 (Low)

Price

A$0.75

Volume

1,011,749

Open

A$0.75

Previous Close

A$0.75

Daily Range

A$0.74 - A$0.76

52-Week Range

A$0.58 - A$0.90

Estimated Earnings Date

Feb 25, 2027

MVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Monash IVF Group

Monash IVF Group Limited is a leading provider of specialized reproductive assistance and women's imaging services, operating across Australia and Malaysia. Founded in 2014 and headquartered in Richmond, Australia, the company offers a comprehensive range of fertility treatments, diagnostic obstetric and gynecological ultrasound examinations, and advanced prenatal diagnostics.

Products and Services
  • In-vitro fertilization (IVF) services
  • Diagnostic obstetric and gynecological ultrasound examinations
  • Advanced tertiary-level prenatal diagnostics
Growth Outlook
  • Expansion into new markets is anticipated to drive revenue growth
  • Increasing demand for fertility treatments supports long-term sustainability
  • Technological advancements in reproductive health enhance service offerings
Financial Highlights
  • Recent quarterly revenue of AUD 131.6 million reflects strong operational performance
  • Trailing twelve months (TTM) net income margin stands at 2.76%
  • Dividend yield of 3.31% indicates a commitment to returning value to shareholders
Monash IVF Group Limited has established itself as a key player in the healthcare sector, particularly in reproductive health. The company's diverse range of services positions it well to capitalize on the growing demand for fertility treatments, driven by societal trends and increasing awareness of reproductive health issues. Recent financial performance highlights a solid revenue base, with a notable net income margin that reflects effective cost management and operational efficiency. The commitment to shareholder returns is evident through a competitive dividend yield, making it an attractive option for potential investors looking for growth in the healthcare industry.
AI Generated • Sep 15, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

892

CEO

Victoria Atkinson, MD

Website

www.monashivfgroup.com.au

Headquarters

Cremorne, VIC 3121, AU

MVF Financials

Key Financial Metrics (TTM)

Gross Margin

22.98%

Operating Margin

7.48%

Net Income Margin

2.76%

Return on Equity

2.95%

Return on Capital

4.61%

Return on Assets

1.45%

Earnings Yield

2.56%

Dividend Yield

3.36%

Payout Ratio

62.98%

Stock Overview

Market Cap

A$290.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

389.63M

Volume

1.01M

Avg. Volume

578.56K

Financials (TTM)

Gross Profit

A$152.25M

Operating Income

A$63.57M

EBITDA

A$110.02M

Operating Cash Flow

A$43.11M

Capital Expenditure

-A$35.37M

Free Cash Flow

A$7.74M

Cash & ST Invst.

A$8.84M

Total Debt

A$199.62M

Monash IVF Group Performance Analysis

Monash IVF Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 213,590,00011.1%
20242024-06-30AUD 254,960,00019.4%
20252025-06-30AUD 271,917,0006.7%
20262026-06-30AUD 269,459,000-0.9%
Monash IVF Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-318.4%
Q42025-06-30-6.3%
Q22025-12-314.8%
Q42026-06-30-4.5%
Monash IVF Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD 0.0618.3%
20242024-06-30AUD -0.02N/A
20252025-06-30AUD 0.06N/A
20262026-06-30AUD 0.02-70.3%
Monash IVF Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31187.5%
Q42025-06-30-52.7%
Q22025-12-31-10.7%
Q42026-06-30-96.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$131.60M

+1.6%

Gross Profit

A$28.59M

-32.0%

Gross Margin

21.72%

N/A

Market Cap

A$290.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$325.42K

N/A

Employees

892

N/A

Net Income

A$265.00K

+101.4%

EBITDA

A$16.46M

+185.8%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$8.84M

-22.0%

Total Debt

A$199.62M

+47.5%

Accounts Receivable

A$17.62M

-42.4%

Inventory

A$10.37M

+26.8%

Long Term Debt

A$188.45M

+47.9%

Short Term Debt

A$11.17M

+39.7%

Return on Assets

1.45%

N/A

Return on Invested Capital

4.51%

N/A

Free Cash Flow

A$4.13M

-78.0%

Operating Cash Flow

A$17.07M

-35.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HLS.AXHealius Limited
A$0.39-1.28%
ACL.AXAustralian Clinical Labs Limited
A$2.86-1.72%
HMD.AXHeraMED Limited
A$0.04-2.70%
BDX.AXBCAL Diagnostics Limited
A$0.09-1.10%

Trending Stocks

Symbol / CompanyPricePrice Chg
KORUDirexion Shares ETF Trust - Direxion Daily Msci South Korea Bull 3x Shares
$15.74-11.82%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$37.19+8.14%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$128.40-8.13%
NOKNokia
$9.90-4.44%

Questions About MVF

What is the current price of Monash IVF Group?

Monash IVF Group is trading at A$0.75 per share.

What is the 52-week range for Monash IVF Group?

Over the past 52 weeks, Monash IVF Group has traded between A$0.58 and A$0.90.

How much debt does Monash IVF Group have?

As of the most recent reporting period, Monash IVF Group reported total debt of A$199.62M.

How much cash does Monash IVF Group have on hand?

Monash IVF Group reported A$8.84M in cash and cash equivalents in its most recent financial results.

What is Monash IVF Group’s dividend yield?

Monash IVF Group currently has a dividend yield of 3.36%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services